1-10 of 10
Barbra Sasu, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML

Surabhi Srinivasan, MS, Nguyen Tan, Hsin-Yuan Cheng, PhD, Yi Zhang, PhD, Silvia Tacheva-Grigorova, MS, Tom Van Blarcom, Cesar Sommer, PhD, Duy Nguyen, Barbra Sasu, PhD, Siler Panowski, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23.
https://doi.org/10.1182/blood-2020-142161
Published: 2020
Journal Articles

Preclinical Evaluation of ALLO-605, an Allogeneic BCMA Turbocar T TM Cell Therapy for the Treatment of Multiple Myeloma

Cesar Sommer, PhD, Regina Lin, PhD, Janette Sutton, Trevor Bentley, Duy Nguyen, Hayung Yoon, Melinda Au, Diego Vargas-Inchaustegui, PhD, Hsin-Yuan Cheng, PhD, Tom Van Blarcom, Siler Panowski, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-141477
Published: 2020
Journal Articles

Allogeneic Anti-Bcma CAR-T Cells Show Tumour Specific Killing Against Primary Multiple Myeloma Cells from Different Genomic Sub-Groups

Ana M Metelo, PhD, Ieuan Walker, BSc, MSc, MBBS, Agnieszka Jozwik, PhD, Charlotte Graham, MRCP, BSc, MBBS, Charlotte Attwood, BMedSci, MBBS, MRCP, FRCPath, Katy Sanchez, BSc, MSc, Alan Dunlop, BSc, MSc, Kirsty Cuthill, FRCPath,MBBS,MRCP,PhD, Carmel Rice, FRACP, FRCPA, MBBS, Matthew Streetly, MD, Trevor Bentley, BSc, Bijan Boldajipour, PhD, Cesar Sommer, PhD, Barbra Sasu, PhD, Reuben Benjamin, FRCPath, MRCP, MBBS, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1834.
https://doi.org/10.1182/blood-2019-124312
Published: 2019
Journal Articles

Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia

Cesar Sommer, PhD, Hsin-Yuan Cheng, PhD, Yik Andy Yeung, PhD, Duy Nguyen, Janette Sutton, Zea Melton, Julien Valton, PhD, Kris Poulsen, Ivana Djuretic, PhD, Thomas Van Blarcom, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3921.
https://doi.org/10.1182/blood-2019-129025
Published: 2019
Journal Articles

Investigation of Allocar T TM Targeting CD70 As a Potential Therapy for an Array of Hematological Malignancies

Siler Panowski, PhD, Surabhi Srinivasan, MS, Thomas Van Blarcom, PhD, Cesar Sommer, PhD, Hsin-Yuan Cheng, PhD, Thomas Pertel, PhD, Marianne A Santaguida, PhD, Roman Galetto, PhD, Alan Dunlop, BSc, MSc, Reuben Benjamin, MD, Barbra Sasu, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5157.
https://doi.org/10.1182/blood-2019-128808
Published: 2019
Journal Articles

ALLO-819, an Allogeneic Flt3 CAR T Therapy Possessing an Off-Switch for the Treatment of Acute Myeloid Leukemia

Cesar Sommer, PhD, Ivana Djuretic, PhD, Julien Valton, PhD, Duy Nguyen, Janette Sutton, Kris Poulsen, Julianne Smith, PhD, Ivana Djuretic, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3335.
https://doi.org/10.1182/blood-2018-99-117605
Published: 2018
Journal Articles

A Novel Full Length Anti-FLT3 CD3 Bispecific Antibody for the Treatment of Acute Myeloid Leukemia

Ivana Djuretic, PhD, Veena Krishnamoorthy, PhD, Cesar Sommer, PhD, Danielle E. Dettling, Kris Poulsen, Wei Chen, PhD, Wenyue Hu, PhD, Allison Given Chunyk, Kevin Lindquist, Shobha Potluri, PhD, Robert C Rickert, PhD, Barbra Sasu, PhD, Javier Chaparro-Riggers, PhD, Yik Andy Yeung, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1445.
https://doi.org/10.1182/blood-2018-99-119915
Published: 2018
Journal Articles

ALLO-715, an Allogeneic BCMA CAR T Therapy Possessing an Off-Switch for the Treatment of Multiple Myeloma

Cesar Sommer, PhD, Bijan Boldajipour, PhD, Julien Valton, PhD, Roman Galetto, PhD, Trevor Bentley, Janette Sutton, Yajin Ni, PhD, Mark Leonard, PhD, Thomas Van Blarcom, PhD, Julianne Smith, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 591.
https://doi.org/10.1182/blood-2018-99-119227
Published: 2018
Journal Articles

Preclinical Evaluation of Allogeneic Anti-Bcma Chimeric Antigen Receptor T Cells with Safety Switch Domains and Lymphodepletion Resistance for the Treatment of Multiple Myeloma

Bijan Boldajipour, PhD, Roman Galetto, PhD, Cesar Sommer, PhD, Thomas Pertel, PhD, Julien Valton, PhD, Yoon Park, PhD, Annabelle Gariboldi, Amy Chen, Tao Geng, Hong H Dong, Gregory R Boucher, Thomas J Van Blarcom, PhD, Javier Chaparro-Riggers, PhD, Arvind Rajpal, PhD, Julianne Smith, PhD, Tracy Kuo, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2016) 128 (22): 381.
https://doi.org/10.1182/blood.V128.22.381.381
Published: 2016
Journal Articles

Preclinical Evaluation of a Potent Anti-Bcma CD3 Bispecific Molecule for the Treatment of Multiple Myeloma

Siler H Panowski, PhD, Tracy Kuo, PhD, Amy Chen, Tao Geng, Thomas J Van Blarcom, PhD, Kevin Lindquist, PhD, Wei Chen, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2016) 128 (22): 383.
https://doi.org/10.1182/blood.V128.22.383.383
Published: 2016